The UM Drug Repurposing Center serves our colleagues within the University to facilitate and develop inventive ways to solve the complex challenges of drug discovery, and improve upon the current implementation standards and responsiveness for investigational drugs. Our hope is that through this center we can enhance drug repurposing resources at UM and support researchers to address unmet medical needs regardless of rarity and representation.


To develop new and novel uses for existing therapeutics in an effort to better understand and treat the unmet medical needs in our community and the overall human condition.


The University of Michigan, with one of the largest extramurally funded research programs in the world, has access to a tremendous wealth of biomedical scientists armed with state-of-the-art in vitro and in vivo disease models to clinician scientists capable of executing large-scale, high-quality clinical trials.  With key opinion leaders in virtually every therapeutic area, the University of Michigan is poised for action to discover and rapidly translate novel pharmacotherapies from bench-side to bed-side.

What can the UM-CDR do for you?

We offer research consultations to help facilitate drug repurposing and to help connect UM investigators with the resources needed.

UM Center for Drug Repurposing Leadership Team

Jonathan Sexton, Ph.D.
Jonathan Sexton, Ph.D.Faculty Director
Assistant Professor of Internal Medicine, Gastroenterology and Hepatology
Kevin Weatherwax
Kevin WeatherwaxManaging Director
Kevin Weatherwax is the managing director of MICHR and the UM CDR
George Mashour, M.D., Ph.D.
George Mashour, M.D., Ph.D.Executive Sponsor
Bert N. La Du Professor of Anesthesiology
Sam Handelman, Ph.D.
Sam Handelman, Ph.D.Director - Clinical Informatics
Assistant Research Professor, Internal Medicine, Gastroenterology and Hepatology
Reid Fursmidt, M.S.
Reid Fursmidt, M.S.Artificial Intelligence Ambassador
Neil Kamdar
Neil KamdarLead Statistician
Kristian Seiler
Kristian SeilerClinical Data Analyst